Page 12 - Repligen Corp News Today

Briefs on local businesspeople

Michael S. Abrams its chief financial officer. In alignment with the company’s succession plan, Abrams joins Arch’s financial team in the role previously held by Richard Davis. Davis will remain with the company during a transition period, which will end on June 30, after which he will support the company in a consulting role through Dec. 31. Abrams has more than 25 years of experience as a chief financial officer to numerous public and private companies; principal investor; investment ba...

Tara A. Kilgallen of Framingham has joined ERA Key as a Realtor in the Framingham office. Kilgallen has 20 years of experience as a yoga instructor in Massachusetts and California, and is currently as instructor at Common Ground Yoga in Framingham. She previously served as co-director of Yoga at Lumina Mind Body Studios - Longfellow Health Clubs in Wayland and She was also a yoga instructor at Bosse Sports in  Sudbury. Before that, she was the director of yoga and retail manager at Tushi...

Repligen: Q1 Earnings Snapshot FacebookTwitterEmail WALTHAM, Mass. (AP) _ Repligen Corp. (RGEN) on Tuesday reported first-quarter profit of $29.5 million. The Waltham, Massachusetts-based company said it had net income of 52 cents per share. Earnings, adjusted for one-time gains and costs, were 68 cents per share. The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 43 cents per share. The drug developer post...

Repligen Corp (RGEN) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Repligen Corp (NASDAQ: RGEN) Operator Good day, ladies and gentlemen, and welcome to Repligen Corporations First Quarter 2021 Earnings Conference Call. My name is Ailey and I will be your coordinator. [Operator Instructions] I would now like to turn the call over to your host for todays call, Sondra Newman, Head of Investor Relations for Re...

Price action over last quarter: Up 8.07% Company Description Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The companys customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the...

ResearchAndMarkets.coms offering. This report on the market for bioprocess filtration is categorized into the following segments: by technology, by products, by end use, and by application. By technology, the market for bioprocess filtration is categorized into tangential flow/cross flow filtration, depth filtration and normal filtration segments. By products, the market is broadly categorized into two groups, namely, systems and consumables and accessories. By application, the market is catego...

Paul Brassil of Medfield has joined the company as senior vice president/chief information officer and will oversee PCU’s information technology and digital innovation efforts. Brassil has more than 25 years of experience in the information technology leadership field with entities such as Commonwealth Medicine (a division of UMass Medical School), the Federal Reserve Bank of Boston, EMC Corp. and Siemens IT Solutions and Services Inc. He holds an MS in computer information systems from Ben...

Paul Brassil of Medfield has joined the company as senior vice president/chief information officer and will oversee PCU’s information technology and digital innovation efforts. Brassil has more than 25 years of experience in the information technology leadership field with entities such as Commonwealth Medicine (a division of UMass Medical School), the Federal Reserve Bank of Boston, EMC Corp. and Siemens IT Solutions and Services Inc. He holds an MS in computer information systems from Ben...

WALTHAM, Mass. (AP) _ Repligen Corp. (RGEN) on Wednesday reported fourth-quarter profit...